Asset
ABBV-257
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02531178 | phase1 | completed | 2015-07-01 | 2016-02-01 | AbbVie | A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis |
FDA applications (0)
This company has no applications containing this asset.